The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment

被引：0
|
作者：
Lambertus P. van den Heuvel
Nicole C. A. J. van de Kar
Caroline Duineveld
Andrei Sarlea
Thea J. A. M. van der Velden
Wilhelmus T. B. Liebrand
Sanne van Kraaij
Camilla Schjalm
Romy Bouwmeester
Jack F. M. Wetzels
Tom E. Mollnes
Elena B. Volokhina
机构：
[1] Radboud Institute for Molecular Life Sciences,Department of Pediatric Nephrology Amalia Children’s Hospital, Radboud University Medical Center
[2] Radboud Institute for Molecular Life Sciences,Department of Laboratory Medicine, Radboud University Medical Center
[3] University Hospitals Leuven,Department of Pediatrics
[4] Radboud Institute for Health Sciences,Department of Nephrology, Radboud University Medical Center
[5] Oslo University Hospital and University of Oslo,Department of Immunology
[6] University of Tromsø,Research Laboratory, Nordland Hospital, Bodø, and K. G. Jebsen TREC
[7] Norwegian University of Science and Technology,Center of Molecular Inflammation Research
来源：
Cellular & Molecular Immunology | 2020年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：653 / 655
页数：2
相关论文
共 50 条
  • [21] SENSITIVE ONE-STEP HEMOLYTIC ASSAYS OF THE 4TH-COMPONENT-(C4) AND 5TH-(C5)-COMPONENT OF THE HUMAN-COMPLEMENT SYSTEM
    SALIHI, AA
    JOISEL, F
    FONTAINE, M
    ANNALES D IMMUNOLOGIE, 1982, C133 (03): : 299 - 307
  • [22] SIMPLIFIED ASSAYS OF HEMOLYTIC-ACTIVITY OF CLASSICAL (CP) AND ALTERNATIVE (AP) COMPLEMENT (C) PATHWAYS
    NILSSON, UR
    NILSSON, B
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 20 (02) : 179 - 179
  • [23] THE PRESENCE OF THE 5TH COMPONENT OF COMPLEMENT (C5) IN RABBIT UTERINE FLUSHINGS IN RELATION TO REPRODUCTIVE STATE
    JONES, MA
    KOLB, WP
    HARPER, MJK
    IMMUNOLOGICAL INVESTIGATIONS, 1988, 17 (01) : 63 - 75
  • [24] PROBLEMS IN COMPLEMENT (C) COMPONENT PURIFICATION - EVIDENCE FOR ACTIVATION OF C5 DURING PURIFICATION AND STORAGE
    DESSAUER, A
    ROTHER, U
    IMMUNOBIOLOGY, 1981, 160 (01) : 18 - 18
  • [25] PREPARATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES AGAINST THE 5TH COMPONENT OF RABBIT COMPLEMENT (C5)
    GICLAS, PC
    BAKER, SL
    GILLESPIE, ML
    WILCOX, C
    JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 105 (02) : 201 - 209
  • [26] STUDIES ON FIFTH COMPONENT OF COMPLEMENT (C5) - COMPARISON OF HEMOLYTIC AND OPSONIC ACTIVITIES IN BOVINE MILK AND HUMAN PLASMA
    GANGES, RG
    MILLER, ME
    PEDIATRIC RESEARCH, 1975, 9 (04) : 329 - 329
  • [27] Role of murine complement component C5 during in vivo infection by pathogenic leptospires
    de Castro, Iris Arantes
    Bavia, Lorena
    Amano, Mariane Tami
    Goncalves da Silva, Ana Maria
    Morais, Zenaide Maria
    Vasconcellos, Silvio Arruda
    de Britto, Thales
    Isaac, Lourdes
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 237 - 237
  • [28] In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway
    Ispasanie, Emma
    Muri, Lukas
    Schmid, Marc
    Schubart, Anna
    Thorburn, Christine
    Zamurovic, Natasa
    Holbro, Thomas
    Kammueller, Michael
    Pluschke, Gerd
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] THE C3/C5 CONVERTASE OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - STABILIZATION AND RESTRICTION OF CONTROL BY LANTHANIDE IONS
    FISHELSON, Z
    MULLEREBERHARD, HJ
    MOLECULAR IMMUNOLOGY, 1983, 20 (03) : 309 - 315
  • [30] THE ABILITY OF H TO MODULATE C5 UTILIZATION BY THE CELL-BOUND ALTERNATIVE PATHWAY C5 CONVERTASE DIFFERS ON SHEEP AND RABBIT ERYTHROCYTES
    FISCHER, E
    JOUVIN, MH
    KAZATCHKINE, M
    AGENTS AND ACTIONS, 1983, 13 (5-6): : 430 - 431
12345